After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Avidity Biosciences Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Avidity Biosciences Inc is $5.93B. A total of 3.21 million shares were traded on the day, compared to an average of 2.31M shares.
In the most recent transaction, STEVEN GEORGE HUGHES bought 9,709 shares of RNA for 46.23 per share on Aug 13 ’25. In a previous transaction on Aug 06 ’25, Mosbrooker Eric sold 130,807 shares at 44.06 per share. RNA shares that Chief Commercial Officer owns now total 55,000.
Among the insiders who sold shares, WILSON TROY EDWARD disposed of 65,554 shares on Aug 06 ’25 at a per-share price of $45.00. This resulted in the Director holding 17,776 shares of RNA after the transaction. In another insider transaction, WILSON TROY EDWARD sold 29,500 shares at $45.00 per share on Aug 06 ’25. Company shares held by the Director now total 69,425.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, RNA has a high of $56.00 and a low of $21.51.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. RNA’s latest balance sheet shows that the firm has $405.54M in Cash & Short Term Investments as of fiscal 2021. There were $11.73M in debt and $29.66M in liabilities at the time. Its Book Value Per Share was $9.87, while its Total Shareholder’s Equity was $381.43M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RNA is Buy with a score of 4.89.
